DRIO - Company ID 0001533998
DarioHealth Corp. trades as DRIO. In its fiscal 2025 annual report the company posted revenue of $22.36M, down 17.3% from the prior year and net income of -$41.71M. This page tracks DarioHealth Corp. through 886 SEC filings, with financial statements and metrics updated as new reports are filed.
Research snapshot
Updated
With latest filings
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
Next research step
Over the last 9 fiscal years DarioHealth Corp.'s revenue grew from $2.80M to $22.36M, a compound annual growth rate of 26.0%. Net profit margin expanded from -388.4% to -186.6% over the same period - every figure below comes from the company's audited annual filings.
Dig into the full income statement, balance sheet, and cash flow statement with annual and quarterly views.
| Filing | Type | Filed |
|---|---|---|
| Quarterly report | 10-Q | 2026-05-13 |
| SD | - | 2026-05-07 |
| New insider ownership | 3 | 2026-04-13 |
| Major company event | 8-K | 2026-04-13 |
| Major company event | 8-K | 2026-03-30 |
| Prospectus supplement | 424B5 | 2026-03-30 |
| EFFECT | - | 2026-03-27 |
| Company correspondence | CORRESP | 2026-03-25 |
The largest companies sharing DarioHealth Corp.'s SEC industry classification (surgical & medical instruments & apparatus).
DarioHealth Corp. reported revenue of $22.36M for fiscal year 2025, a decrease of 17.3% year over year.
In its latest fiscal year DarioHealth Corp. reported a net loss of $41.71M.